Ciliary Neurotrophic Factor (CNTF) Phase I Trial for Human Retinal Degenerations. In The 35th Annual Meeting for the Society for Neuroscience. presented at the 12/11/2005, Washington, DC.. (2005).
Intravitreal Ranibizumab for Treatment of Retinal Capillary Hemangioblastoma (RCH) Related to von-Hippel Lindau (VHL) Disease. In Association for Research in Vision and Ophthalmology (ARVO). presented at the 27/04/2008, Ft. Lauderdale, FL.. (2008).
Ciliary Neurotrophic Factor (CNTF) For Human Retinal Neurodegeneration: Phase I Trial of CNTF Delivered by Encapsulated Cell Intraocular Implants. Proceedings of the National Academy of Science, 103, 3896-901. presented at the 2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16505355. (2006).
Evaluation of the Age-Related Eye Disease Study Clinical Lens Grading System AREDS Report No. 31. Ophthalmology, 117, 2112-2119.e3. presented at the 11/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20561686. (2010).
Intravitreal Anti-VEGF Therapy for Advanced Ocular Disease of Von Hippel-Lindau Disease. presented at the 2004.. (2004).
Preliminary Assessment of Celecoxib and Microdiode Pulse Laser Treatment of Diabetic Macular Edema. Retina, 30, 459-467. presented at the 03/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20038863. (2010).